Aleix Fabregat

Grupo de investigación

Biomarcadores y medicina de precisión de laboratorio en hepatología, metabolismo y enfermedades raras (HEMERA-Lab) Accredited researcher (R3A)

afabregat@clinic.cat 0000-0002-4855-0306

Síguelo/a en:

Publicaciones destacadas

Overdiagnosed and oversupplemented: the iatrogenic rise of vitamin D toxicity

Autores:
Fabregat-Bolufer, Aleix B; Martin-Alonso, Carlos; Escola-Rodriguez, Alba; Morales-Ruiz, Manuel;

Referencia: EUROPEAN JOURNAL OF ENDOCRINOLOGY 2026.
Can AI Outperform Human Aspirants? Evaluating 3 ChatGPT Models on the Spanish FIR and BIR Specialized Health Examinations

Autores:
Verdu, Gonzalo; Rayo, Alejandro Calvera; Fabregat-Bolufer, Aleix B;

Referencia: Journal Of Applied Laboratory Medicine 2025.
Data-Driven Reference Intervals in Modern Laboratory Medicine: New Web Tools to Refine Vitamin D Status

Autores:
Barragan Munoz, Alex; Fabregat-Bolufer, Aleix B;

Referencia: Journal Of Applied Laboratory Medicine 2025.
Comparison of two automated immunoassays for quantifying ProGRP, SCC and HE4 in serum: impact on diagnostic accuracy

Autores:
de Medrano, Jaime I Sainz; Laguna, Javier; Julian, Judit; Filella, Xavier; Fabregat, Aleix;

Luquin, Maria; Hurtado, Harol H; Humanes, Alba Garcia; Morales-Ruiz, Manuel; Fernandez-Galan, Esther.

Referencia: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION 2025.
Redefining vitamin D status: Establishing population-based indirect reference intervals through big data analysis

Autores:
Fabregat-Bolufer, Aleix B; Escola-Rodriguez, Alba; Bedini-Chesa, Jose Luis; Casals, Gregori; Morales-Ruiz, Manuel;

Filella, Xavier.

Referencia: CLINICA CHIMICA ACTA 2025.
Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia

Autores:
Pineyroa, Juan A; Lopez-Oreja, Irene; Nadeu, Ferran; Martinez-Farran, Ares; Arostegui, Juan Ignacio;

(...)

Bea, Silvia; Campo, Elias; Delgado, Julio; Colomer, Dolors; Mozas, Pablo.

Referencia: Cells 2024.
Diagnosis of cocaine-induced midline destructive lesions

Autores:
Escola-Rodriguez, Alba; Parra-Robert, Marina; Carrasco-Gomez, Daniel; Escartin-Diez, Teresa; Fabregat-Bolufer, Aleix B;

Referencia: CLINICAL TOXICOLOGY 2023.
Antibiotic susceptibility and genotypic characterization of Neisseria gonorrhoeae isolates in the Comunidad Valenciana (Spain) GONOvig project

Autores:
Aleix Borja Fabregat Bolufer; Felipe Bueno Ferrando; David Navarro Ortega; Javier Colomina Rodríguez;

Referencia: 2023.
Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact

Autores:
Mozas, Pablo; Pineyroa, Juan A; Nadeu, Ferran; Magnano, Laura; Rivero, Andrea;

(...)

Arostegui, Juan Ignacio; Aymerich, Marta; Lopez-Guillermo, Armando; Campo, Elias; Delgado, Julio.

Referencia: HAEMATOLOGICA 2021.
Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma

Autores:
Mozas, Pablo; Rivero, Andrea; Rivas-Delgado, Alfredo; Fabregat, Aleix; Pineyroa, Juan A;

(...)

Campo, Elias; Arostegui, Juan I; Blade, Joan; Magnano, Laura; Lopez-Guillermo, Armando.

Referencia: BRITISH JOURNAL OF HAEMATOLOGY 2021.

Proyectos destacados

Treatment of metabolic liver disease using gold nanoenzymes with multicatalytic activity

Investigador/a principal: Gregori Casals Mercadal

Financiador: Instituto de Salud Carlos III (ISCIII)

Código: PI24/00688

Duración: 01/01/2025 - 31/12/2027
Function and therapeutic potential of RNA helicases and miR-122a-5p in liver regeneration and cancer

Investigador/a principal: Manuel Morales Ruiz

Financiador: Agencia Estatal de Investigacion (AEI)

Código: PID2022-138243OB-I00

Duración: 01/10/2024 - 31/03/2026
Proyecto GONOvig

Financiador: Hospital de la Ribera

Código: PIBR17/04

Duración: 01/03/2017

Web: https://roderic.uv.es/items/7c1f2c1f-7d54-4e9d-b5d2-dfcdd26c92c3

Aleix Fabregat

Grupo de investigación

Publicaciones destacadas

Proyectos destacados

Treatment of metabolic liver disease using gold nanoenzymes with multicatalytic activity

Function and therapeutic potential of RNA helicases and miR-122a-5p in liver regeneration and cancer

Proyecto GONOvig

Suscríbete a la Newsletter del Clínic